1.
2.
3.
4.
5.
6.
7.
8.
Zhang, S.; Dai, M.; Wang, X.; Jiang, S.H.; Hu, L.P.; Zhang, X.L.; Zang, Z.G. Signaling entrains the peripheral circadian clock. Cell
Signal. 2020, 69, 109443. [CrossRef] [PubMed]
Jiang, Y.; Li, S.; Xu, W.; Ying, J.; Qu, Y.; Jiang, X.; Zhang, A.; Yue, Y.; Zhou, R.; Ruan, T.; et al. Critical Roles of the Circadian
Transcription Factor BMAL1 in Reproductive Endocrinology and Fertility. Front. Endocrinol. 2022, 13, 818272. [CrossRef]
[PubMed]
Zhang, S.J.; Qian, H.N.; Zhao, Y.; Sun, K.; Wang, H.Q.; Liang, G.Q.; Li, F.H.; Li, Z. Relationship between age and prostate size.
Asian J. Androl. 2013, 15, 116–120. [CrossRef] [PubMed]
Roehrborn, C.G. Pathology of benign prostatic hyperplasia. Int. J. Impot. Res. 2008, 20, S11–S18. [CrossRef] [PubMed]
Elkahwaji, J.E. The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer. Res. Rep.
Urol. 2012, 5, 1. [CrossRef] [PubMed]
Vital, P.; Castro, P.; Ittmann, M. Oxidative stress promotes benign prostatic hyperplasia. Prostate 2016, 76, 58–67. [CrossRef]
[PubMed]
Wang, Z.; Olumi, A.F. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic
hyperplasia. Differentiation 2011, 82, 261–271. [CrossRef]
Alvarez, J.D.; Hansen, A.; Ord, T.; Bebas, P.; Chappell, P.E.; Giebultowicz, J.M.; Williams, C.; Moss, S.; Sehgal, A. The circadian
clock protein BMAL1 is necessary for fertility and proper testosterone production in mice. J. Biol. Rhythm. 2008, 23, 26–36.
[CrossRef]
Int. J. Mol. Sci. 2022, 23, 11272
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
10 of 10
Yang, L.; Ma, T.; Zhao, L.; Jiang, H.; Zhang, J.; Liu, D.; Zhang, L.; Wang, X.; Pan, T.; Zhang, H.; et al. Circadian regulation of
apolipoprotein gene expression affects testosterone production in mouse testis. Theriogenology 2021, 174, 9–19. [CrossRef]
Kondratov, R.V.; Kondratova, A.A.; Gorbacheva, V.Y.; Vykhovanets, O.V.; Antoch, M.P. Early aging and age-related pathologies in
mice deficient in BMAL1, the core componentof the circadian clock. Genes Dev. 2006, 20, 1868–1873. [CrossRef]
Bebas, P.; Goodall, C.P.; Majewska, M.; Neumann, A.; Giebultowicz, J.M.; Chappell, P.E. Circadian clock and output genes are
rhythmically expressed in extratesticular ducts and accessory organs of mice. FASEB J. 2009, 23, 523–533. [CrossRef] [PubMed]
Birbach, A. Use of PB-Cre4 mice for mosaic gene deletion. PLoS ONE 2013, 8, e53501. [CrossRef] [PubMed]
Shimba, S.; Ogawa, T.; Hitosugi, S.; Ichihashi, Y.; Nakadaira, Y.; Kobayashi, M.; Tezuka, M.; Kosuge, Y.; Ishige, K.; Ito, Y.; et al.
Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS
ONE 2011, 6, e25231. [CrossRef] [PubMed]
Okada, Y.; Sonoshita, M.; Kakizaki, F.; Aoyama, N.; Itatani, Y.; Uegaki, M.; Sakamoto, H.; Kobayashi, T.; Inoue, T.; Kamba, T.; et al.
Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer. Cancer Sci. 2017, 108,
744–752. [CrossRef]
Gréchez-Cassiau, A.; Rayet, B.; Guillaumond, F.; Teboul, M.; Delaunay, F. The circadian clock component BMAL1 is a critical
regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J. Biol. Chem. 2008, 283, 4535–4542. [CrossRef]
Harper, J.W.; Adami, G.R.; Keyomarsi, N.W.K.; Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1
cyclin-dependent kinases. Cell 1993, 75, 805–816. [CrossRef]
Shidaifat, F.; Canatan, H.; Kulp, S.K.; Sugimoto, Y.; Zhang, Y.; Brueggemeier, R.W.; Somers, W.J.; Chang, W.Y.; Wang, H.C.; Lin,
Y.C. Gossypol arrests human benign prostatic hyperplastic cell growth at G0/G1 phase of the cell cycle. Anticancer Res. 1997, 17,
1003–1009.
Pannek, J.; Berges, R.R.; Sauvageot, J.; Lecksell, K.L.; Epstein, J.I.; Partin, A.W. Cell turnover in human seminal vesicles and the
prostate: An immunohistochemical study. Prostate Cancer Prostatic Dis. 1999, 2, 200–203. [CrossRef]
Cao, Q.; Gery, S.; Dashti, A.; Yin, D.; Zhou, Y.; Gu, J.; Koeffler, H.P. A role for the clock gene per1 in prostate cancer. Cancer Res.
2009, 69, 7619–7625. [CrossRef]
Kaur, P.; Mohamed, N.E.; Archer, M.; Figueiro, M.G.; Kyprianou, N. Impact of Circadian Rhythms on the Development and
Clinical Management of Genitourinary Cancers. Front. Oncol. 2022, 12, 759153. [CrossRef]
Jin, C.; McKeehan, K.; Wang, F. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and
ductus deferens. Prostate 2003, 57, 160–164. [CrossRef] [PubMed]
Ohmiya, H.; Vitezic, M.; Frith, M.C.; Itoh, M.; Carninci, P.; Forrest, A.R.; Hayashizaki, Y.; Lassmann, T.; FANTOM Consortium.
RECLU: A pipeline to discover reproducible transcriptional start sites and their alternative regulation using capped analysis of
gene expression (CAGE). BMC Genom. 2014, 15, 269. [CrossRef] [PubMed]
Zhou, Y.; Zhou, B.; Pache, L.; Chang, M.; Khodabakhshi, A.H.; Tanaseichuk, O.; Benner, C.; Chanda, S.K. Metascape provides a
biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019, 10, 1523. [CrossRef] [PubMed]
Kanda, Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl. 2013, 48,
452–458. [CrossRef]
...
論文の公開元へ
